Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Shiyun Lv, Lijun Sun, Tongzeng Li, Ruojing Bai, Man Dai, Ran Wang, Yuanyi Zhai, Wei Hua, Aixin Li, Ruolei Xin & Lili Dai. (2023) Role of Proviral HIV-1 DNA Genotyping for People Living with HIV (PLWH) Who Had Low-Level Viremia While Receiving Antiretroviral Therapy. Infection and Drug Resistance 16, pages 4697-4706.
Read now
Read now
Quang Duy Pham, Thu Khanh Hoang Huynh, Tram Thu Luong, Ton Tran, Thinh Xuan Vu & Lien Xuan Thi Truong. (2013) HIV-1 Drug Resistance and Associated Factors Among Adults Failing First-Line Highly Active Antiretroviral Therapy in Ho Chi Minh City, Vietnam. HIV Clinical Trials 14:1, pages 34-44.
Read now
Read now
Sara Chandy, Girija Singh, Elsa Heylen, Monica Gandhi & MariaL. Ekstrand. (2011) Treatment switching in South Indian patients on HAART: what are the predictors and consequences?. AIDS Care 23:5, pages 569-577.
Read now
Read now
Articles from other publishers (43)
Sandra Liliana Valderrama-Beltrán, Samuel Martínez-Vernaza, Shirley Vanessa Correa-Forero, Maria Alejandra Jaimes-Reyes, Leonardo Arévalo-Mora, Ernesto Martínez-Buitrago, Julieta Franco, Claudia Beltrán-Rodríguez, Juan Urrego-Reyes, Sebastian Leon, Martha García Garzon, Claudia Gonzalez, Norberto Fonseca, Monica Botero, Javier Andrade, Diana Alzamora, William Lenis, José Pardo, Juan Alzate-Ángel, Monica Mantilla, Otto Sussmann, Leonardo Montero-Riascos & Carlos Arturo Álvarez-Moreno. (2023) Reasons for antiretroviral switching in Colombia: A retrospective cohort study. International Journal of STD & AIDS 34:13, pages 921-931.
Crossref
Crossref
Nicholus Nanyeenya, Damalie Nakanjako, Fredrick Makumbi, Gertrude Nakigozi, Fred Nalugoda, Godfrey Kigozi, Esther Nasuuna, Simon P. S. Kibira, Susan Nabadda, Charles Kiyaga, Mutyaba Huzaifah & Noah Kiwanuka. (2023) Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low‐level viraemia in Uganda. HIV Medicine.
Crossref
Crossref
Bianchuan CaoMei LiuTao JiangQinghua YuTianru YuanPing DingXian ZhouFuli HuangYongmao HuangJianning Jiang. (2023) HIV-1 RNA and DNA Genotyping Drug Resistance Detection in Patients with Low-Level Viremia in Liangshan, China. AIDS Research and Human Retroviruses 39:8, pages 429-435.
Crossref
Crossref
Hailiang Yu, Yuecheng Yang, Dongdong Cao, Yan Zhao, Cong Jin, Haolan Sun, Yanfen Cao, Runhua Ye, Shitang Yao, Song Duan & Zunyou Wu. (2022)
Association of low‐level viremia with mortality among people living with
HIV
on antiretroviral therapy in Dehong, Southwest China: A retrospective cohort study
. HIV Medicine 24:1, pages 37-45.
Crossref
Crossref
Cheng-Te Lee, Hsin-Pai Chen, Hsi-Hsun Lin, Meng-Yu Ke & Ping-Feng Wu. (2022) The influence of low-level viremia on CD4+ cell count in human immunodeficiency virus–infected patients. Journal of the Chinese Medical Association 85:12, pages 1126-1130.
Crossref
Crossref
Qun Li, Fengting Yu, Chuan Song, Hongxin Zhao, Liting Yan, Qing Xiao, Xiaojie Lao, Siyuan Yang, Yunxia Tang, Jiang Xiao & Fujie Zhang. (2022) A Concentration Method for HIV Drug Resistance Testing in Low-Level Viremia Samples. BioMed Research International 2022, pages 1-6.
Crossref
Crossref
Nicholus Nanyeenya, Noah Kiwanuka, Damalie Nakanjako, Gertrude Nakigozi, Simon P.S. Kibira, Susan Nabadda, Charles Kiyaga, Isaac Sewanyana, Esther Nasuuna & Fredrick Makumbi. (2022) Low-level viraemia: An emerging concern among people living with HIV in Uganda and across sub-Saharan Africa. African Journal of Laboratory Medicine 11:1.
Crossref
Crossref
Ontlametse T Bareng, Sikhulile Moyo, Melissa Zahralban-Steele, Dorcas Maruapula, Tsotlhe Ditlhako, Baitshepi Mokaleng, Patrick Mokgethi, Wonderful T Choga, Natasha O Moraka, Molly Pretorius-Holme, Madisa O Mine, Elliot Raizes, Kesaobaka Molebatsi, Modisa S Motswaledi, Irene Gobe, Terence Mohammed, Tendani Gaolathe, Roger Shapiro, Mompati Mmalane, Joseph M Makhema, Shahin Lockman, Max Essex, Vlad Novitsky, Simani Gaseitsiwe, Helen Ayles, Lucie Abeler-Dörner, David Bonsall, Rory Bowden, Max Essex, Sarah Fidler, Christophe Fraser, Kate Grabowski, Tanya Golubchik, Ravindra Gupta, Richard Hayes, Joshua Herbeck, Joseph Kagaayi, Pontiano Kaleebu, Jairam Lingappa, Vladimir Novitsky, Sikhulile Moyo, Deenan Pillay, Thomas Quinn, Andrew Rambaut, Oliver Ratmann, Janet Seeley, Deogratius Ssemwanga, Frank Tanser & Maria Wawer. (2022) HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana. Journal of Antimicrobial Chemotherapy 77:5, pages 1385-1395.
Crossref
Crossref
Ruojing Bai, Shiyun Lv, Hao Wu & Lili Dai. (2022) Low-level Viremia in Treated HIV-1 Infected Patients: Advances and
Challenges. Current HIV Research 20:2, pages 111-119.
Crossref
Crossref
Allison Navis, Ifunanya Dallah, Charles Mabeta, Kalo Musukuma, Omar K. Siddiqi, Christopher M. Bositis, Igor J. Koralnik, Harris A. Gelbard, William H. Theodore, Jason F. Okulicz, Brent A. Johnson, Izukanji Sikazwe, David R. Bearden & Gretchen L Birbeck. (2020) Evaluating the impact of antiretroviral and antiseizure medication interactions on treatment effectiveness among outpatient clinic attendees with HIV in Zambia. Epilepsia 61:12, pages 2705-2711.
Crossref
Crossref
Shahria Mohammad Rashed Ul Islam, Munira Jahan, Afzalun Nessa & Shahina Tabassum. (2019) Response to First-Line Antiretroviral Therapy Among PLHIV from a High-Risk, Low-Prevalence Setting. Journal of the International Association of Providers of AIDS Care (JIAPAC) 18, pages 232595821986732.
Crossref
Crossref
Enrique Bernal, Jose M. Gómez, Inma Jarrín, Alfredo Cano, Angeles Muñoz, Antonia Alcaraz, Arkaitz Imaz, Jose A. Iribarren, María Rivero, Piedad Arazo & Félix Gutiérrez. (2018) Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment. JAIDS Journal of Acquired Immune Deficiency Syndromes 78:3, pages 329-337.
Crossref
Crossref
Helen M Chun, Yaa F Obeng-Aduasare, Laura N Broyles & Dennis Ellenberger. (2017) Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance. The Journal of Infectious Diseases 216:suppl_9, pages S808-S811.
Crossref
Crossref
Jennifer S. Lee, Stephen R. Cole, David B. Richardson, Dirk P. Dittmer, William C. Miller, Richard D. Moore, Mari Kitahata, Christopher Mathews, Kenneth Mayer, Elvin Geng, Chad J. Achenbach & Joseph J. Eron. (2017) Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation. AIDS 31:14, pages 1989-1997.
Crossref
Crossref
Shivani Gupta, Tracy Taylor, Aileen Patterson, Binhua Liang, Jared Bullard, Paul Sandstrom, Gary Van Domselaar & Hezhao Ji. (2017) A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples. BioMed Research International 2017, pages 1-6.
Crossref
Crossref
Ragna S. Boerma, T. Sonia Boender, Anton P. Bussink, Job C. J. Calis, Silvia Bertagnolio, Tobias F. Rinke de Wit, Michael Boele van Hensbroek & Kim C.E. Sigaloff. (2016) Suboptimal Viral Suppression Rates Among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-analysis. Clinical Infectious Diseases 63:12, pages 1645-1654.
Crossref
Crossref
A. Gonzalez-Serna, L.C. Swenson, B. Watson, W. Zhang, A. Nohpal, K. Auyeung, J.S. Montaner & P.R. Harrigan. (2016) A single untimed plasma drug concentration measurement during low-level HIV viremia predicts virologic failure. Clinical Microbiology and Infection 22:12, pages 1004.e9-1004.e16.
Crossref
Crossref
Duncan Churchill, Laura Waters, Nadia Ahmed, Brian Angus, Marta Boffito, Mark Bower, David Dunn, Simon Edwards, Carol Emerson, Sarah Fidler, Martin Fisher, Rob Horne, Saye Khoo, Clifford Leen, Nicola Mackie, Neal Marshall, Fernando Monteiro, Mark Nelson, Chloe Orkin, Adrian Palfreeman, Sarah Pett, Andrew Phillips, Frank Post, Anton Pozniak, Iain Reeves, Caroline Sabin, Roy Trevelion, John Walsh, Ed Wilkins, Ian Williams & Alan Winston. (2016)
British HIV Association guidelines for the treatment of
HIV
‐1‐positive adults with antiretroviral therapy 2015
. HIV Medicine 17:S4.
Crossref
Crossref
Jordi Navarro, Estrella Caballero, Adrian Curran, Joaquin Burgos, Inma Ocaña, Vicenç Falcó, Ariadna Torrella, Mercè Pérez, Esteban Ribera & Manuel Crespo. (2015) Impact of Low-Level Viraemia on Virological Failure in HIV-1-Infected Patients with Stable Antiretroviral Treatment. Antiviral Therapy 21:4, pages 345-352.
Crossref
Crossref
Quang Duy Pham, David P. Wilson, Thuong Vu Nguyen, Nhan Thi Do, Lien Xuan Truong, Long Thanh Nguyen & Lei Zhang. (2016) Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies. Journal of Antimicrobial Chemotherapy 71:5, pages 1367-1379.
Crossref
Crossref
Sangeetha Vijaysri Nair, Hee Cheol Kim, Jacqueline Fortunko, Tracy Foote, Tashi Peling, Cuong Tran, Charles Thomas Nugent, Sunghae Joo, Youna Kang, Bana Wilkins, Kristen Lednovich & Andrew Worlock. (2016) Aptima HIV-1 Quant Dx—A fully automated assay for both diagnosis and quantification of HIV-1. Journal of Clinical Virology 77, pages 46-54.
Crossref
Crossref
Timothy R. Buisker, Mi-Suk Kang Dufour & Janet J. Myers. (2015) Recall of Nadir CD4 Cell Count and Most Recent HIV Viral Load Among HIV-Infected, Socially Marginalized Adults. AIDS and Behavior 19:11, pages 2108-2116.
Crossref
Crossref
Noémie Boillat-Blanco, Katharine EA Darling, Franziska Schoni-Affolter, Danielle Vuichard, Mathieu Rougemont, Rosamaria Fulchini, Enos Bernasconi, Manel Aouri, Olivier Clerc, Hansjakob Furrer, Huldrych F Günthard, Matthias Cavassini, V Aubert, M Battegay, E Bernasconi, J Böni, HC Bucher, C Burton-Jeangros, A Calmy, M Cavassini, G Dollenmaier, M Egger, L Elzi, J Fehr, J Fellay, H Furrer, CA Fux, M Gorgievski, H Günthard, D Haerry, B Hasse, HH Hirsch, M Hoffmann, I Hösli, C Kahlert, L Kaiser, O Keiser, T Klimkait, R Kouyos, H Kovari, B Ledergerber, G Martinetti, De Tejada B Martinez, K Metzner, N Müller, D Nadal, D Nicca, G Pantaleo, A Rauch, S Regenass, M Rickenbach, C Rudin, F Schöni-Affolter, P Schmid, J Schüpbach, R Speck, P Tarr, A Telenti, A Trkola, P Vernazza, R Weber & S Yerly. (2014) Virological Outcome and Management of Persistent Low-Level Viraemia in HIV-1-Infected Patients: 11 Years of the Swiss HIV Cohort Study. Antiviral Therapy 20:2, pages 165-175.
Crossref
Crossref
. (2015) Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients. AIDS 29:3, pages 373-383.
Crossref
Crossref
Saran Vardhanabhuti, Babafemi Taiwo, Daniel R Kuritzkes, Joseph J EronJrJr & Ronald J Bosch. (2015) Phylogenetic Evidence of HIV-1 Sequence Evolution in Subjects with Persistent Low-Level Viraemia. Antiviral Therapy 20:1, pages 73-76.
Crossref
Crossref
Silvia BaroncelliMaria Franca PirilloClementina Maria GalluzzoAnna Degli AntoniNicoletta LadisaDaniela FrancisciGabriella d'EttorreDaniela SegalaAngela VivarelliFederica SozioOscar CirioniLiliana Elena WeimerVincenzo FragolaGiustino ParrutiMarco Floridia. (2015) Rate and Determinants of Residual Viremia in Multidrug-Experienced Patients Successfully Treated with Raltegravir-Based Regimens. AIDS Research and Human Retroviruses 31:1, pages 71-77.
Crossref
Crossref
BARBARA SZOMOLAY & EDWARD M. LUNGU. (2014) A MATHEMATICAL MODEL FOR THE TREATMENT OF AIDS-RELATED KAPOSI'S SARCOMA. Journal of Biological Systems 22:03, pages 495-522.
Crossref
Crossref
Luke C. Swenson, Jeong Eun Min, Conan K. Woods, Eric Cai, Jonathan Z. Li, Julio S.G. Montaner, P. Richard Harrigan & Alejandro Gonzalez-Serna. (2014) HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure. AIDS 28:8, pages 1125-1134.
Crossref
Crossref
A. Gonzalez-Serna, J. E. Min, C. Woods, D. Chan, V. D. Lima, J. S. G. Montaner, P. R. Harrigan & L. C. Swenson. (2014) Performance of HIV-1 Drug Resistance Testing at Low-Level Viremia and Its Ability to Predict Future Virologic Outcomes and Viral Evolution in Treatment-Naive Individuals. Clinical Infectious Diseases 58:8, pages 1165-1173.
Crossref
Crossref
. (2013) 7.0 Managing virological failure. HIV Medicine 15:S1, pages 48-57.
Crossref
Crossref
C. Laprise, A. de Pokomandy, J.-G. Baril, S. Dufresne & H. Trottier. (2013) Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation. Clinical Infectious Diseases 57:10, pages 1489-1496.
Crossref
Crossref
Annelot F. Schoffelen, Annemarie M. J. Wensing, Hugo A. Tempelman, Sibyl P. M. Geelen, Andy I. M. Hoepelman & Roos E. Barth. (2013) Sustained Virological Response on Second-Line Antiretroviral Therapy following Virological Failure in HIV-Infected Patients in Rural South Africa. PLoS ONE 8:3, pages e58526.
Crossref
Crossref
Gudrun Naeth, Robert Ehret, Frank Wiesmann, Patrick Braun, Heribert Knechten & Annemarie Berger. (2012) Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia. Medical Microbiology and Immunology 202:1, pages 67-75.
Crossref
Crossref
Michael R. Jordan, Julie Winsett, Aileen Tiro, Vuth Bau, Rony S. Berbara, Christopher Rowley, Nobel Bellosillo, Christine Wanke & Eoin P. Coakley. (2013) HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low Levels. World Journal of AIDS 03:02, pages 71-78.
Crossref
Crossref
Jean Ruelle, Laurent Debaisieux, Ellen Vancutsem, Annelies De Bel, Marie-Luce Delforge, Denis Piérard & Patrick Goubau. (2012) HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability. BMC Infectious Diseases 12:1.
Crossref
Crossref
Jonathan Z. Li, Sebastien Gallien, Tri D. Do, Jeffrey N. Martin, Steven Deeks, Daniel R. Kuritzkes & Hiroyu Hatano. (2012) Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level Viremia. Antimicrobial Agents and Chemotherapy 56:11, pages 5998-6000.
Crossref
Crossref
. (2012) 7.0 Managing virological failure. HIV Medicine 13:S2, pages 47-56.
Crossref
Crossref
Louise Kuhn, Ashraf Coovadia, Renate Strehlau, Leigh Martens, Chih-Chi Hu, Tammy Meyers, Gayle Sherman, Gillian Hunt, Deborah Persaud, Lynn Morris, Wei-Yann Tsai & Elaine J Abrams. (2012) Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial. The Lancet Infectious Diseases 12:7, pages 521-530.
Crossref
Crossref
Chun ChaoBeth TangWilliam TownerMichael J. SilverbergLeo HurleyMichael Horberg. (2012) Short-Term Clinical Outcomes Among Treatment-Experienced HIV-Positive Patients with Early Low Level Viremia. AIDS Patient Care and STDs 26:5, pages 253-255.
Crossref
Crossref
G Martin-Blondel, K Sauné, V Vu Hai, B Marchou, P Delobel, J Izopet, L Cuzin & P Massip. (2012) Factors associated with a strictly undetectable viral load in HIV-1-infected patients. HIV Medicine, pages n/a-n/a.
Crossref
Crossref
J.C. Karasi, F. Dziezuk, L. Quennery, S. Förster, U. Reischl, G. Colucci, D. Schoener, C. Seguin-Devaux & J.C. Schmit. (2011) High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes. Journal of Clinical Virology 52:3, pages 181-186.
Crossref
Crossref
T. Tony Trinh, Brian T. Montague, Timothy P. Flanigan & Hoang My Gerard. (2011) HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City. AIDS Research and Treatment 2011, pages 1-7.
Crossref
Crossref
Caroline A Sabin. (2010) Cohort studies: to what extent can they inform treatment guidelines?. Current Opinion in Infectious Diseases 23:1, pages 15-20.
Crossref
Crossref